Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.998
+0.008 (0.76%)
Mar 9, 2026, 3:44 PM EDT - Market open

Standard BioTools Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
38449265117593300
Upgrade
Market Cap Growth
-23.65%-24.44%271.28%89.12%-69.06%-32.58%
Upgrade
Enterprise Value
219325375458322376
Upgrade
Last Close Price
0.991.281.752.211.173.92
Upgrade
PS Ratio
4.405.773.741.650.952.30
Upgrade
PB Ratio
0.901.161.381.080.403.17
Upgrade
P/TBV Ratio
0.891.161.97---
Upgrade
EV/Sales Ratio
2.573.812.154.303.292.88
Upgrade
Debt / Equity Ratio
0.070.070.070.600.451.18
Upgrade
Net Debt / Equity Ratio
-0.37-0.37-0.55-0.10-0.280.88
Upgrade
Net Debt / EBITDA Ratio
1.901.902.200.350.75-1.30
Upgrade
Net Debt / FCF Ratio
1.901.901.710.360.68-1.45
Upgrade
Asset Turnover
0.140.140.370.300.290.44
Upgrade
Inventory Turnover
1.411.412.942.662.884.89
Upgrade
Quick Ratio
1.861.864.961.234.210.94
Upgrade
Current Ratio
4.194.195.701.454.811.45
Upgrade
Return on Equity (ROE)
-13.13%-13.13%-43.75%-37.99%-117.21%-50.71%
Upgrade
Return on Assets (ROA)
-9.88%-9.88%-18.01%-11.05%-18.61%-14.06%
Upgrade
Return on Capital Employed (ROCE)
-20.30%-20.30%-24.70%-29.50%-28.60%-29.90%
Upgrade
Earnings Yield
-19.93%-15.21%-21.32%-42.55%-204.90%-19.76%
Upgrade
FCF Yield
-22.00%-16.79%-23.30%-26.28%-100.45%-19.12%
Upgrade
Buyback Yield / Dilution
-8.03%-8.03%-346.24%-1.09%-3.32%-5.19%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.